Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PerkinElmer Inc (NYSE:PKI)

69.37
Delayed Data
As of Jul 24
 -0.15 / -0.22%
Today’s Change
45.35
Today|||52-Week Range
70.16
+33.02%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$7.6B

Company Description

PerkinElmer, Inc. (United States) provides products, services and solutions to diagnostics, food, environmental, industrial, life sciences research, and laboratory services. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that helps life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.

Contact Information

PerkinElmer, Inc. (United States)
940 Winter Street
Waltham Massachusetts 02451
P:(781) 663-6900
Investor Relations:
(781) 663-5889

Employees

Shareholders

Mutual fund holders66.04%
Other institutional28.93%
Individual stakeholders2.29%

Top Executives

Robert F. FrielChairman, President & Chief Executive Officer
Andy WilsonChief Financial Officer & Senior Vice President
James L. CorbettSenior Vice President & President-Human Health
Deborah ButtersChief Human Resources Officer & SVP
Prahlad Ramadhar SinghSenior Vice President & President-Diagnostics